Hadas Nicole R. has filed 13 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 12016 shares of Akebia Therapeutics, Inc. ($AKBA) on May 13, 2024.
Activity breakdown: 0 open-market purchases and 8 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 12016 | $1.26 | 651,243.0000 | 187,465,448 | 1.81% | 0.01% |
| Feb. 29, 2024 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 5974 | $1.58 | 663,259.0000 | 187,465,448 | 0.89% | 0.00% |
| Feb. 27, 2024 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 7411 | $1.52 | 669,233.0000 | 187,465,448 | 1.10% | 0.00% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | A | Common Stock | 149300 | $0.00 | 676,644.0000 | 187,465,448 | 28.31% | 0.08% |
| Jan. 31, 2024 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | A | Stock Option (Right to buy) | 224000 | $0.00 | 224,000.0000 | 187,465,448 | 9999.99% | 0.12% |
| May 24, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | A | Common Stock | 200000 | $0.00 | 587,530.0000 | 0 | 51.61% | 0.00% |
| May 25, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 63186 | $1.22 | 524,344.0000 | 0 | 10.75% | 0.00% |
| May 24, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | A | Employee Stock Option (Right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | A | Common Stock | 100000 | $0.00 | 387,530.0000 | 0 | 34.78% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 5333 | $0.88 | 295,231.0000 | 0 | 1.77% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 6613 | $0.88 | 288,618.0000 | 0 | 2.24% | 0.00% |
| March 1, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 1088 | $0.88 | 287,530.0000 | 0 | 0.38% | 0.00% |
| Feb. 27, 2023 | Akebia Therapeutics, Inc. | $AKBA | Hadas Nicole R. | SVP, Chief Legal Officer | S | Common Stock | 6677 | $0.81 | 300,564.0000 | 0 | 2.17% | 0.00% |